Prolong Pharmaceuticals
Dr. Nikunj Patel is the President of Prolong Pharmaceuticals, a clinical-stage biopharmaceutical company with novel therapeutics. He also currently holds an Executive Vice President role at Kashiv Biosciences, where he oversees their clinical development for both their biosimilar and 5050(b)(2) portfolios. He brings over 18 years of leadership experience as a pharmacologist in all phases of clinical drug development, including global registration trials, drug development processes, and clinical trial design. Prior to joining Prolong, Dr. Patel built his technical expertise in numerous leadership roles, most notably as EVP and Head of Operations at Amneal Pharmaceuticals, where he played several key roles across the entire development of several blockbusters products. Dr. Patel also has a successful track record within major roles at clinical research organizations, designing and supervising a large variety of global clinical trials. Dr. Patel earned his MD degree from B.J Medical College India.
This person is not in any offices
Prolong Pharmaceuticals
Headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC is developing products to treat several diseases and their debilitating comorbidities which cause reduced quality of life, increased medical costs and significant mortality.